Related Experiment Video
Updated: Oct 20, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.6K
Recent clinical trials in atrial fibrillation
Thomas Flautt1, Miguel Valderrábano
1Division of Electrophysiology, Department of Cardiology, Department of Medicine, Houston Methodist Debakey, Houston, Texas, USA.
Current Opinion in Cardiology
|September 14, 2021
Summary
Recent atrial fibrillation trials show early rhythm control, including ablation, is superior to rate control. Novel ablation techniques offer new hope for persistent atrial fibrillation management.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) management presents challenges due to vast information and treatment options.
- Physicians need to process rapid advancements in AF technology and medications.
Purpose of the Study:
- To review landmark and clinically relevant trials in atrial fibrillation published within the last 18-24 months.
- To highlight the impact of recent clinical trials on current AF practice.
Main Methods:
- Review of key clinical trials and subanalyses in atrial fibrillation.
- Focus on studies published within the last 2 years.
Main Results:
- Early rhythm control with ablation or antiarrhythmic drugs is favored over rate control for AF.
- Vein of Marshall alcohol ablation combined with other techniques shows promise for persistent AF.
- Cryoballoon ablation demonstrates efficacy in symptomatic paroxysmal AF compared to antiarrhythmic therapy.
Conclusions:
- Early rhythm control strategies are transforming AF management.
- Innovative ablation approaches are emerging for complex AF cases.
- Recent evidence supports early intervention for symptomatic AF patients.
